Benedikt Kranzbühler
YOU?
Author Swipe
View article: Simultaneous Autophagy and Androgen Receptor Inhibition in a Prostate Cancer Xenograft Model
Simultaneous Autophagy and Androgen Receptor Inhibition in a Prostate Cancer Xenograft Model Open
Objective: Abi, when used in conjunction with prednisone, is an established treatment for advanced PCa. Our goal was to explore the level of autophagy induced by Abi treatment, both alone and in combination with the autophagy inhibitor Chl…
View article: Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin
Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin Open
PSMA expression gradually increases from benign prostatic hyperplasia to adenocarcinoma of the prostate and is therefore used for the development of improved diagnostic (PSMA)-based prostate cancer imaging tools. Pharmacological induction …
View article: Illumination matters Part III: Impact of light obstruction on illuminance from flexible ureteroscopes — a comparative PEARLS analysis
Illumination matters Part III: Impact of light obstruction on illuminance from flexible ureteroscopes — a comparative PEARLS analysis Open
View article: Advancing Intraoperative Assessment of Urethral Stricture Anatomic Variation: A Prospective Proof-of-Concept Study
Advancing Intraoperative Assessment of Urethral Stricture Anatomic Variation: A Prospective Proof-of-Concept Study Open
Introduction: Urethral strictures, particularly those refractory to endoscopic interventions, are commonly treated through open urethroplasty. However, predicting recurrence in homogeneous patient populations remains challeng…
View article: Proposal and clinical validation of a perioperative algorithm enhancing antimicrobial stewardship in substitution urethroplasty
Proposal and clinical validation of a perioperative algorithm enhancing antimicrobial stewardship in substitution urethroplasty Open
A standardized protocol such as the one introduced improves antibiotic stewardship through frequent testing and culture-specific treatment. This is crucial in avoiding unnecessary antimicrobial treatment, and reducing infectious events and…
View article: Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro
Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro Open
Prostate-specific membrane antigen (PSMA)-based imaging improved the detection of primary, recurrent and metastatic prostate cancer. However, in certain patients, a low PSMA surface expression can be a limitation for this promising diagnos…
View article: Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer
Limited Value of Bladder Wash Cytology During Follow-Up of Patients With Non-muscle Invasive Bladder Cancer Open
View article: Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?
Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified? Open
Patients with non-muscle invasive (NMI) urothelial bladder cancer (BC) are at increased risk for the development of a secondary upper-urinary-tract urothelial carcinoma (UTUC). We aimed to assess the usefulness of routine upper-tract imagi…
View article: Apalutamide and autophagy inhibition in a xenograft mouse model of human prostate cancer
Apalutamide and autophagy inhibition in a xenograft mouse model of human prostate cancer Open
View article: Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis
Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis Open
View article: 68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer
68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer Open
View article: Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study Open
View article: Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison
Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison Open
View article: Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data Open
View article: The Role of Frozen Section Examination During Inguinal Exploration in Men with Inconclusive Testicular Tumors: A Systematic Review and Meta-analysis
The Role of Frozen Section Examination During Inguinal Exploration in Men with Inconclusive Testicular Tumors: A Systematic Review and Meta-analysis Open
View article: Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cells
Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cells Open
View article: Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria
Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria Open
View article: Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 Patients
Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 Patients Open
Background Sertoli cell tumors (SCTs) of the testes are rare, and the literature provides only weak evidence concerning their clinical course and management. The objective of this study was to summarize evidence on SCTs’ clinical presentat…
View article: Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with <sup>68</sup>Ga-PSMA-11-PET
Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with <sup>68</sup>Ga-PSMA-11-PET Open
Prostate-specific membrane antigen (PSMA) targeted PET has a high detection rate for biochemical recurrence (BCR) of prostate cancer (PCa). Nevertheless, even at high prostate-specific antigen (PSA) levels (> 3 ng/ml), a relevant number of…
View article: A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis
A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis Open
View article: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors Open
CXCL12 is almost exclusively expressed in non-seminoma. Pure seminoma, GCNIS and adjacent normal testicular tissue are CXCL12 negative. Our analysis suggests that patients with metastatic disease and a CXCL12-positive non-seminoma are at h…
View article: Detection Rate and Localization of Prostate Cancer Recurrence Using <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL
Detection Rate and Localization of Prostate Cancer Recurrence Using <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL Open
A first analysis of simultaneous 68Ga-prostate-specific membrane antigen (PSMA)-11 PET/MRI showed some improvement in the detection of recurrent disease at low serum prostate specific antigen (PSA) values below 0.5 ng/mL compare…
View article: MP68-03 DUTASTERIDE ENHANCES PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) SURFACE EXPRESSION AND UPTAKE OF <sup>177</sup> LU-PSMA-617 IN VITRO
MP68-03 DUTASTERIDE ENHANCES PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) SURFACE EXPRESSION AND UPTAKE OF <sup>177</sup> LU-PSMA-617 IN VITRO Open
You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II (MP68)1 Apr 2019MP68-03 DUTASTERIDE ENHANCES PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) SURFACE EXPRESSION AND UPTAKE OF 177LU-PSMA-617 IN VITRO Benedikt …
View article: PD17-07 DETECTION RATE OF 68GA-PSMA-11 PET/MRI IN PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY AND LOW PSA VALUES ≤ 0.5 NG/ML
PD17-07 DETECTION RATE OF 68GA-PSMA-11 PET/MRI IN PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY AND LOW PSA VALUES ≤ 0.5 NG/ML Open
You have accessJournal of UrologyProstate Cancer: Staging II (PD17)1 Apr 2019PD17-07 DETECTION RATE OF 68GA-PSMA-11 PET/MRI IN PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY AND LOW PSA VALUES ≤ 0.5 NG/ML Benedikt …
View article: <sup>68</sup>Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU
<sup>68</sup>Ga-PSMA-11 PET/MR Detects Local Recurrence Occult on mpMRI in Prostate Cancer Patients After HIFU Open
High-intensity focused ultrasound (HIFU) is a promising new modality for the treatment of localized prostate cancer (PCa). Follow-up of patients is recommended with biopsies and multiparametric MRI (mpMRI). However, mpMRI in the postinterv…
View article: Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment
Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment Open
View article: Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer
Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer Open
View article: Issue Information ‐ Editorial Board
Issue Information ‐ Editorial Board Open
Rest of World), €6139 (Europe), £4854 (UK).Prices are exclusive of tax.Asia-Pacifi c GST, Canadian GST/HST and European VAT will be applied at the appropriate rates.For more information on current tax rates, please go to www.wileyonlinelib…
View article: MP64-13 COMBINED N-TERMINAL ANDROGEN RECEPTOR AND AUTOPHAGY INHIBITION INCREASES THE ANTI-TUMOR EFFECT IN ENZALUTAMIDE-SENSITIVE AND ENZALUTAMIDE-RESISTANT LNCAP CELLS
MP64-13 COMBINED N-TERMINAL ANDROGEN RECEPTOR AND AUTOPHAGY INHIBITION INCREASES THE ANTI-TUMOR EFFECT IN ENZALUTAMIDE-SENSITIVE AND ENZALUTAMIDE-RESISTANT LNCAP CELLS Open
You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2018MP64-13 COMBINED N-TERMINAL ANDROGEN RECEPTOR AND AUTOPHAGY INHIBITION INCREASES THE ANTI-TUMOR EFFECT IN ENZALUTAMIDE-SENSITIVE AND ENZALUTAMID…
View article: MP08-06 EFFICIENCY OF BLADDER WASH CYTOLOGY DURING SURVEILLANCE OF NON-MUSCLE INVASIVE BLADDER CANCER: ANALYSIS IN A CONTEMPORARY PATIENT COHORT
MP08-06 EFFICIENCY OF BLADDER WASH CYTOLOGY DURING SURVEILLANCE OF NON-MUSCLE INVASIVE BLADDER CANCER: ANALYSIS IN A CONTEMPORARY PATIENT COHORT Open
You have accessJournal of UrologyBladder Cancer: Non-invasive I1 Apr 2018MP08-06 EFFICIENCY OF BLADDER WASH CYTOLOGY DURING SURVEILLANCE OF NON-MUSCLE INVASIVE BLADDER CANCER: ANALYSIS IN A CONTEMPORARY PATIENT COHORT Benedikt Kranzbühler,…